Drinking liquids in thyroid cancer therapy with I-131

Evaluating the relation between the quantities of drank liquids and delivered dose to body of cancer thyroid patients treated with I-131

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014051417684N1

Enrollment

Registered

2014-08-01

Start date

2014-07-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer. Malignant neoplasm of thyroid gland

Interventions

Controlling quantities of drank liquids.

Prevention

Controlling quantities of drank liquids

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: thyroid cancer patients who treated with I-131 at nuclear medicine department in Namazi Hospital, shiraz, Iran. Exclusion criteria: vomitting

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ambient equivalent dose. Timepoint: Before and after intervention. Method of measurement: Environmental dosimeter.	—

Secondary

Measure	Time frame
Physiological characteristics of the patient. Timepoint: Before intervention. Method of measurement: Measurement and asking patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNuclear medicine and molecular imaging research center

Shiraz university of medical science

nmmirc@yahoo.com+98 71 1612 5330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026